UniProt ID | DCR1B_HUMAN | |
---|---|---|
UniProt AC | Q9H816 | |
Protein Name | 5' exonuclease Apollo | |
Gene Name | DCLRE1B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 532 | |
Subcellular Localization | Chromosome, telomere. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Mainly localizes to telomeres, recruited via its interaction with TERF2. During mitosis, localizes to the centrosome. | |
Protein Description | 5'-3' exonuclease that plays a central role in telomere maintenance and protection during S-phase. Participates in the protection of telomeres against non-homologous end-joining (NHEJ)-mediated repair, thereby ensuring that telomeres do not fuse. Plays a key role in telomeric loop (T loop) formation by being recruited by TERF2 at the leading end telomeres and by processing leading-end telomeres immediately after their replication via its exonuclease activity: generates 3' single-stranded overhang at the leading end telomeres avoiding blunt leading-end telomeres that are vulnerable to end-joining reactions and expose the telomere end in a manner that activates the DNA repair pathways. Together with TERF2, required to protect telomeres from replicative damage during replication by controlling the amount of DNA topoisomerase (TOP1, TOP2A and TOP2B) needed for telomere replication during fork passage and prevent aberrant telomere topology. Also involved in response to DNA damage: plays a role in response to DNA interstrand cross-links (ICLs) by facilitating double-strand break formation. In case of spindle stress, involved in prophase checkpoint.. | |
Protein Sequence | MNGVLIPHTPIAVDFWSLRRAGTARLFFLSHMHSDHTVGLSSTWARPLYCSPITAHLLHRHLQVSKQWIQALEVGESHVLPLDEIGQETMTVTLLDANHCPGSVMFLFEGYFGTILYTGDFRYTPSMLKEPALTLGKQIHTLYLDNTNCNPALVLPSRQEAAHQIVQLIRKHPQHNIKIGLYSLGKESLLEQLALEFQTWVVLSPRRLELVQLLGLADVFTVEEKAGRIHAVDHMEICHSNMLRWNQTHPTIAILPTSRKIHSSHPDIHVIPYSDHSSYSELRAFVAALKPCQVVPIVSRRPCGGFQDSLSPRISVPLIPDSVQQYMSSSSRKPSLLWLLERRLKRPRTQGVVFESPEESADQSQADRDSKKAKKEKLSPWPADLEKQPSHHPLRIKKQLFPDLYSKEWNKAVPFCESQKRVTMLTAPLGFSVHLRSTDEEFISQKTREEIGLGSPLVPMGDDDGGPEATGNQSAWMGHGSPLSHSSKGTPLLATEFRGLALKYLLTPVNFFQAGYSSRRFDQQVEKYHKPC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
17 | Phosphorylation | PIAVDFWSLRRAGTA CEEECHHHHHCCCHH | 16.40 | 24719451 | |
52 | Ubiquitination | ARPLYCSPITAHLLH CCCCCCCHHHHHHHH | 25.12 | 29967540 | |
178 | Ubiquitination | KHPQHNIKIGLYSLG HCCCCCCEEEEEECC | 35.72 | 29967540 | |
245 | Ubiquitination | CHSNMLRWNQTHPTI CHHHCCCCCCCCCEE | 9.42 | 22817900 | |
246 | Ubiquitination | HSNMLRWNQTHPTIA HHHCCCCCCCCCEEE | 30.36 | 22817900 | |
248 | Ubiquitination | NMLRWNQTHPTIAIL HCCCCCCCCCEEEEE | 26.98 | 22817900 | |
249 | Ubiquitination | MLRWNQTHPTIAILP CCCCCCCCCEEEEEE | 14.03 | 22817900 | |
251 | Ubiquitination | RWNQTHPTIAILPTS CCCCCCCEEEEEECC | 18.55 | 29967540 | |
261 | Ubiquitination | ILPTSRKIHSSHPDI EEECCCCCCCCCCCE | 3.56 | 29967540 | |
272 | Ubiquitination | HPDIHVIPYSDHSSY CCCEEEECCCCCCCH | 22.83 | 29967540 | |
281 | Ubiquitination | SDHSSYSELRAFVAA CCCCCHHHHHHHHHH | 33.76 | 29967540 | |
285 | Ubiquitination | SYSELRAFVAALKPC CHHHHHHHHHHHCCC | 2.88 | 29967540 | |
290 | Ubiquitination | RAFVAALKPCQVVPI HHHHHHHCCCEEEEE | 38.73 | - | |
294 | Ubiquitination | AALKPCQVVPIVSRR HHHCCCEEEEEEECC | 7.62 | 29967540 | |
309 | Phosphorylation | PCGGFQDSLSPRISV CCCCCCCCCCCCCCC | 21.69 | 24719451 | |
311 | Phosphorylation | GGFQDSLSPRISVPL CCCCCCCCCCCCCCC | 18.98 | 30266825 | |
320 | Ubiquitination | RISVPLIPDSVQQYM CCCCCCCCHHHHHHH | 35.19 | 22817900 | |
333 | Sumoylation | YMSSSSRKPSLLWLL HHCCCCCCHHHHHHH | 40.69 | 28112733 | |
333 | Ubiquitination | YMSSSSRKPSLLWLL HHCCCCCCHHHHHHH | 40.69 | - | |
335 | Phosphorylation | SSSSRKPSLLWLLER CCCCCCHHHHHHHHH | 38.85 | 24719451 | |
356 | Phosphorylation | TQGVVFESPEESADQ CCCCEECCHHHCCCH | 26.58 | 25849741 | |
360 | Phosphorylation | VFESPEESADQSQAD EECCHHHCCCHHHHH | 35.17 | 27732954 | |
364 | Phosphorylation | PEESADQSQADRDSK HHHCCCHHHHHHHHH | 28.08 | 27732954 | |
371 | Ubiquitination | SQADRDSKKAKKEKL HHHHHHHHHHHHHHC | 62.12 | 22817900 | |
372 | Ubiquitination | QADRDSKKAKKEKLS HHHHHHHHHHHHHCC | 70.19 | 22817900 | |
374 | Ubiquitination | DRDSKKAKKEKLSPW HHHHHHHHHHHCCCC | 71.05 | 22817900 | |
375 | Ubiquitination | RDSKKAKKEKLSPWP HHHHHHHHHHCCCCC | 66.01 | 22817900 | |
377 | Ubiquitination | SKKAKKEKLSPWPAD HHHHHHHHCCCCCCC | 64.24 | 29967540 | |
379 | Phosphorylation | KAKKEKLSPWPADLE HHHHHHCCCCCCCCC | 35.67 | 25849741 | |
387 | Ubiquitination | PWPADLEKQPSHHPL CCCCCCCCCCCCCCC | 74.85 | 29967540 | |
398 | Ubiquitination | HHPLRIKKQLFPDLY CCCCHHHHHHCHHHH | 50.27 | 29967540 | |
407 | Ubiquitination | LFPDLYSKEWNKAVP HCHHHHCCHHHHHCC | 53.87 | 29967540 | |
411 | Ubiquitination | LYSKEWNKAVPFCES HHCCHHHHHCCCHHC | 52.41 | 29967540 | |
420 | Ubiquitination | VPFCESQKRVTMLTA CCCHHCCCCEEEEEC | 59.10 | 29967540 | |
444 | Phosphorylation | STDEEFISQKTREEI CCCHHHHCHHHHHHH | 30.83 | 17525332 | |
446 | Ubiquitination | DEEFISQKTREEIGL CHHHHCHHHHHHHCC | 42.64 | 21906983 | |
490 | Phosphorylation | LSHSSKGTPLLATEF CCCCCCCCCCCCCHH | 17.94 | 28555341 | |
507 | Phosphorylation | LALKYLLTPVNFFQA HHHHHHHCCCCHHHC | 23.69 | 25849741 | |
516 | Phosphorylation | VNFFQAGYSSRRFDQ CCHHHCCCCCHHHHH | 13.39 | 25849741 | |
528 | Phosphorylation | FDQQVEKYHKPC--- HHHHHHHHCCCC--- | 11.11 | 20058876 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DCR1B_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DCR1B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DCR1B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TERF2_HUMAN | TERF2 | physical | 16606622 | |
FACD2_HUMAN | FANCD2 | physical | 18469862 | |
MRE11_HUMAN | MRE11A | physical | 18469862 | |
RAD50_HUMAN | RAD50 | physical | 18469862 | |
CH60_HUMAN | HSPD1 | physical | 26496610 | |
PRKDC_HUMAN | PRKDC | physical | 26496610 | |
TERF1_HUMAN | TERF1 | physical | 26496610 | |
TERF2_HUMAN | TERF2 | physical | 26496610 | |
POTE1_HUMAN | POT1 | physical | 26496610 | |
TINF2_HUMAN | TINF2 | physical | 26496610 | |
TE2IP_HUMAN | TERF2IP | physical | 26496610 | |
FBP1L_HUMAN | FNBP1L | physical | 26496610 | |
KANL2_HUMAN | KANSL2 | physical | 26496610 | |
S39AA_HUMAN | SLC39A10 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
305000 | Hoyeraal-Hreidarsson syndrome (HHS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-444, AND MASSSPECTROMETRY. |